CoChat
Sign Up
Cited by 67

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer

Coe, B P, Lockwood, W W, Girard, L, Chari, R, MacAulay, C, Lam, S, Gazdar, A F, Minna, J D, Lam, W L·2006·British Journal of Cancer
DOI 10.1038/sj.bjc.6603167PMC PMC2361340
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6603167

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The 88 genes differentially expressed in both cohorts included known EGFRMUT-associated genes ETV5 and NKX2-1.

    “The 88 genes showed clear differential expression across EGFRMUT and EGFRWT tumors and contained known EGFRMUT associated genes such as ETV5 and NKX2-118, 19.”

    From Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis (2019) · cites this paper as [19]

    The Results and Discussion section identifies 159 genes differentially expressed between small-cell and non-small-cell lung cancer cell lines, not genes associated with EGFR mutation status. Searches for ETV5, NKX2-1, and EGFR-mutant versus wild-type tumors found no passage establishing the association attributed to this source; the citing paper’s 88-gene result is not something this source can verify. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. Amann J, Kalyankrishna S, Massion PP, Ohm JE, Girard L, Shigematsu H, Peyton M, Juroske D, Huang Y, Stuart Salmon J, Kim YH, Pollack JR, Yanagisawa K, Gazdar A, Minna JD, Kurie JM, Carbone DP (2005) Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res 65: 226–235 · DOI
  2. Balsara BR, Testa JR (2002) Chromosomal imbalances in human lung cancer. Oncogene 21: 6877–6883 · DOI
  3. Campos EI, Chin MY, Kuo WH, Li G (2004) Biological functions of the ING family tumor suppressors. Cell Mol Life Sci 61: 2597–2613 · DOI
  4. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL (2004) SeeGH – a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5: 13 · DOI
  5. Coe BP, Lee HL, Chi B, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL (2006) Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small cell lung cancer cell lines. Genes Chromosomes Cancer 45: 11–19 · DOI
  6. de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, Staudt LM, Martinez-Climent JA, Lam WL (2004) Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13: 1827–1837 · DOI
  7. Einarson MB, Cukierman E, Compton DA, Golemis EA (2004) Human enhancer of invasion-cluster, a coiled-coil protein required for passage through mitosis. Mol Cell Biol 24: 3957–3971 · DOI
  8. Fogh J, Wright WC, Loveless JD (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58: 209–214 · DOI · Paper page
  9. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439–5447 · DOI
  10. Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL (2006) High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 118: 1556–1564 · DOI
  11. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD (2000) Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60: 4894–4906
  12. Henderson LJ, Coe BP, Lee EH, Girard L, Gazdar AF, Minna JD, Lam S, MacAulay C, Lam WL (2005) Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells. Br J Cancer 92: 1553–1560 · DOI
  13. Hyodo-Miura J, Urushiyama S, Nagai S, Nishita M, Ueno N, Shibuya H (2002) Involvement of NLK and Sox11 in neural induction in Xenopus development. Genes Cells 7: 487–496 · DOI · Paper page
  14. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, Lam WL (2004) A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299–303 · DOI
  15. Jin DY, Kozak CA, Pangilinan F, Spencer F, Green ED, Jeang KT (1999) Mitotic checkpoint locus MAD1L1 maps to human chromosome 7p22 and mouse chromosome 5. Genomics 55: 363–364 · DOI
  16. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B (2004) Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20: 3636–3637. Epub 16 June 2004 · DOI
  17. Kurup A, Hanna NH (2004) Treatment of small cell lung cancer. Crit Rev Oncol Hematol 52: 117–126 · DOI
  18. Li W, Guan KL (2004) The Down syndrome cell adhesion molecule (DSCAM) interacts with and activates Pak. J Biol Chem 279: 32824–32831. Epub 28 May 2004 · DOI
  19. Lundberg AS, Weinberg RA (1999) Control of the cell cycle and apoptosis. Eur J Cancer 35: 1886–1894 · DOI
  20. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945–2949 · DOI
  21. Oguri T, Isobe T, Suzuki T, Nishio K, Fujiwara Y, Katoh O, Yamakido M (2000) Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int J Cancer 86: 95–100 · DOI
  22. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108 · DOI
  23. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T (1997a) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57: 2331–2335
  24. Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M (1997b) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75: 79–86 · DOI
  25. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila RI, Matthews MJ, Bunn Jr PA, Carney D, Minna JD, Mulshine JL (1996) NCI-Navy Medical Oncology Branch cell line database. J Cell Biochem 24(Suppl): 32–91 · DOI
  26. Polager S, Ginsberg D (2003) E2F mediates sustained G2 arrest and downregulation of Stathmin and AIM-1 expression in response to genotoxic stress. J Biol Chem 278: 1443–1449. Epub 21 November 2002 · DOI
  27. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, Milchgrub S, Smith AL, Souza RF, Gilbey L, Zhang X, Gandia K, Vaughan MB, Wright WE, Gazdar AF, Shay JW, Minna JD (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027–9034 · DOI
  28. Ritter CA, Jedlitschky G, Meyer zu Schwabedissen H, Grube M, Kock K, Kroemer HK (2005) Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev 37: 253–278 · DOI
  29. Rostad H, Naalsund A, Jacobsen R, Eirik Strand T, Scott H, Heyerdahl Strom E, Norstein J (2004) Small cell lung cancer in Norway. Should more patients have been offered surgical therapy? Eur J Cardiothorac Surg 26: 782–786 · DOI
  30. Rubin CI, Atweh GF (2004) The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93: 242–250 · DOI
  31. Sakamuro D, Prendergast GC (1999) New Myc-interacting proteins: a second Myc network emerges. Oncogene 18: 2942–2954 · DOI
  32. Sasahira T, Akama Y, Fujii K, Kuniyasu H (2005) Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch 446: 411–415. Epub 24 March 2005 · DOI
  33. Schneider R, Bannister AJ, Kouzarides T (2002) Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27: 396–402 · DOI
  34. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20: 2390–2400 · DOI
  35. Stupp R, Monnerat C, Turrisi III AT, Perry MC, Leyvraz S (2004) Small cell lung cancer: state of the art and future perspectives. Lung Cancer 45: 105–117 · DOI
  36. Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K (2004) Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib (‘Iressa’, ZD1839). Oncol Rep 12: 1053–1057
  37. Tomoda R, Seto M, Tsumuki H, Iida K, Yamazaki T, Sonoda J, Matsumine A, Uchida A (2002) Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer 95: 1127–1133 · DOI
  38. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y, Khatry DB, Protopopov A, You MJ, Aguirre AJ, Martin ES, Yang Z, Ji H, Chin L, Depinho RA (2005) High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 102: 9625–9630 · DOI
  39. Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata H, Fujimoto T, Tomonaga M, Sawyers C, Said JW, Koeffler HP (2001) Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 20: 3301–3305 · DOI
  40. Watson SK, deLeeuw RJ, Ishkanian AS, Malloff CA, Lam WL (2004) Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high-resolution CGH arrays. BMC Genomics 5: 6 · DOI
  41. Weaver DA, Crawford EL, Warner KA, Elkhairi F, Khuder SA, Willey JC (2005) ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol Cancer 4: 18 · DOI
  42. Williams BC, Li Z, Liu S, Williams EV, Leung G, Yen TJ, Goldberg ML (2003) Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions. Mol Biol Cell 14: 1379–1391 · DOI
  43. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG (2003) Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351–360 · DOI
  44. Yamagishi N, Saito Y, Ishihara K, Hatayama T (2002) Enhancement of oxidative stress-induced apoptosis by Hsp105alpha in mouse embryonal F9 cells. Eur J Biochem 269: 4143–4151 · DOI
  45. Zabarovsky ER, Lerman MI, Minna JD (2002) Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21: 6915–6935 · DOI
  46. Zakowski MF (2003) Pathology of small cell carcinoma of the lung. Semin Oncol 30: 3–8 · DOI
  47. Zebedee Z, Hara E (2001) Id proteins in cell cycle control and cellular senescence. Oncogene 20: 8317–8325 · DOI
  48. Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, Sugarbaker D, Chen F, Rubin MA, Janne PA, Girard L, Minna J, Christiani D, Li C, Sellers WR, Meyerson M (2005) Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65: 5561–5570 · DOI

Cited by

Sorted by citations

Metadata

Authors
Coe, B. P., Lockwood, W. W., Girard, L., Chari, R., MacAulay, C., Lam, S., Gazdar, A. F., Minna, J. D., & Lam, W. L.
Venue
British Journal of Cancer
Publisher
Springer Science and Business Media LLC
Published
2006-05-16
Volume
94
Issue
12
Pages
1927-1935
ISSN
  • 0007-0920
  • 1532-1827
DOI
10.1038/sj.bjc.6603167
PMC
PMC2361340
Cited by
67
References
4
Language
en
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review